INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
AK

Audhya Paul K.

CHIEF MEDICAL OFFICERCIK 0001860131

EDGAR filingsOpen in network
Disclosed transactions25
Buys / sells0 / 5
Max Insider Score31
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
93.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    KalVista Pharmaceuticals, Inc.CHIEF MEDICAL OFFICER · Nov 19, 2025
5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D
—
150.3K sh
Jun 11, 2026
Jun 11, 2026
traded Jun 11, 2026
+0d
SEC FORM 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
25.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC FORM 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
100.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC FORM 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
40.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC FORM 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
68.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC FORM 4

Evidence

11
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
5,000 sh
May 22, 2026May 27, 2026
traded May 22, 2026
+5dSEC FORM 4

Evidence

20
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$60K
2,239 sh
May 26, 2026May 27, 2026
traded May 26, 2026
+1dSEC FORM 4

Evidence

15
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
5,000 sh
May 22, 2026May 27, 2026
traded May 22, 2026
+5dSEC FORM 4

Evidence

15
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
May 21, 2026May 26, 2026
traded May 21, 2026
+5dSEC FORM 4

Evidence

20
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$72K
2,685 sh
May 22, 2026May 26, 2026
traded May 22, 2026
+4dSEC FORM 4

Evidence

11
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
May 21, 2026May 26, 2026
traded May 21, 2026
+5dSEC FORM 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

30
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$54K
2,686 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC FORM 4

Evidence

9
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

11
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Grant or award
A—
100.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC FORM 4

Evidence

15
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
Nov 21, 2025Nov 26, 2025
traded Nov 21, 2025
+5dSEC FORM 4

Evidence

11
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
5,000 sh
Nov 22, 2025Nov 26, 2025
traded Nov 22, 2025
+4dSEC FORM 4

Evidence

30
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$71K
5,296 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC FORM 4

Evidence

11
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
Nov 21, 2025Nov 26, 2025
traded Nov 21, 2025
+5dSEC FORM 4

Evidence

15
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
5,000 sh
Nov 22, 2025Nov 26, 2025
traded Nov 22, 2025
+4dSEC FORM 4

Evidence

13
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,447 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence

31
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$45K
3,075 sh
Nov 18, 2025Nov 19, 2025
traded Nov 18, 2025
+1dSEC FORM 4

Evidence

21
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
2,419 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence

9
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
4,028 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence